Trial
NCT04580238
Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alberta
Collaborators
—
Condition
Stroke (CVA) or TIA
Intervention
Botox 200 UNT Injection
Why stopped
Logistical issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19